These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 20197200)

  • 1. Polymorphisms of the gamma-glutamyl hydrolase gene and risk of relapse to acute lymphoblastic leukemia in Mexico.
    Organista-Nava J; Gómez-Gómez Y; Saavedra-Herrera MV; Rivera-Ramírez AB; Terán-Porcayo MA; Alarcón-Romero Ldel C; Illades-Aguiar B; Leyva-Vázquez MA
    Leuk Res; 2010 Jun; 34(6):728-32. PubMed ID: 20197200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of a 452C/T single nucleotide polymorphism in γ-glutamyl hydrolase gene in children with acute leukemia].
    Zhang HH; Yue LJ; Chen XW; Zhao W; Hu CY; Zheng MM; Yang CL; Xie C
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Jun; 29(3):352-5. PubMed ID: 22678806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between polymorphisms of dihydrofolate reductase and gamma glutamyl hydrolase genes and toxicity of high dose methotrexate in children with acute lymphoblastic leukemia.
    Koomdee N; Hongeng S; Apibal S; Pakakasama S
    Asian Pac J Cancer Prev; 2012; 13(7):3461-4. PubMed ID: 22994778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotyping of single nucleotide polymorphism in γ-glutamyl hydrolase gene by capillary electrophoresis.
    Cheng HL; Chiou SS; Liao YM; Chen YL; Wu SM
    Electrophoresis; 2011 Aug; 32(15):2021-7. PubMed ID: 21538980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.
    Pakakasama S; Kanchanakamhaeng K; Kajanachumpol S; Udomsubpayakul U; Sirachainan N; Thithapandha A; Hongeng S
    Ann Hematol; 2007 Aug; 86(8):609-11. PubMed ID: 17323057
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic responses in childhood acute lymphoblastic leukemia (ALL) and haplotypes of gamma glutamyl hydrolase (GGH) gene.
    Garcia-Bournissen F; Moghrabi A; Krajinovic M
    Leuk Res; 2007 Jul; 31(7):1023-5. PubMed ID: 16999998
    [No Abstract]   [Full Text] [Related]  

  • 7. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the effect of 3 glucocorticoid receptor gene polymorphisms on risk of relapse in 100 Iranian children with acute lymphoblastic leukemia: a case-control study.
    Namazi S; Zareifar S; Monabati A; Ansari S; Karimzadeh I
    Clin Ther; 2011 Mar; 33(3):280-90. PubMed ID: 21497906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.
    Aplenc R; Thompson J; Han P; La M; Zhao H; Lange B; Rebbeck T
    Cancer Res; 2005 Mar; 65(6):2482-7. PubMed ID: 15781665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
    Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
    Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency distribution of five SNPs in human
    Li M; Wang SM; Wu WS; Yan D; Zhang LP; Zheng HY
    Pharmazie; 2020 Apr; 75(4):142-146. PubMed ID: 32295690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylenetetrahydrofolate reductase gene polymorphisms and risk of acute lymphoblastic leukemia in children.
    Sadananda Adiga MN; Chandy S; Ramachandra N; Appaji L; Aruna Kumari BS; Ramaswamy G; Savithri HS; Krishnamoorthy L
    Indian J Cancer; 2010; 47(1):40-5. PubMed ID: 20071789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methotrexate concentrations in cerebrospinal fluid and serum, and the risk of central nervous system relapse in children with acute lymphoblastic leukaemia.
    Jönsson P; Höglund P; Wiebe T; Schrøder H; Seidel H; Skärby T
    Anticancer Drugs; 2007 Sep; 18(8):941-8. PubMed ID: 17667600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients.
    Chiusolo P; Reddiconto G; Farina G; Mannocci A; Fiorini A; Palladino M; La Torre G; Fianchi L; Sorà F; Laurenti L; Leone G; Sica S
    Leuk Res; 2007 Dec; 31(12):1669-74. PubMed ID: 17512587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
    Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
    Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTHFR 677 (C-->T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95.
    Seidemann K; Book M; Zimmermann M; Meyer U; Welte K; Stanulla M; Reiter A
    Ann Hematol; 2006 May; 85(5):291-300. PubMed ID: 16463153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemia.
    Hattori H; Suminoe A; Wada M; Koga Y; Kohno K; Okamura J; Hara T; Matsuzaki A
    Leuk Res; 2007 Dec; 31(12):1633-40. PubMed ID: 17568669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional genetic risk factor for death in children with acute lymphoblastic leukemia: a common polymorphism of the MTHFR gene.
    Pietrzyk JJ; Bik-Multanowski M; Balwierz W; Skoczen S; Wojcik D; Chybicka A; Sikorska-Fic B; Matysiak M; Szczepanski T; Sonta-Jakimczyk D; Ploszynska A; Balcerska A; Mycko K; Bodalski J; Krawczuk-Rybak M; Kowalczyk J; Koltan A; Sobol G; Derwich K; Kwinta P
    Pediatr Blood Cancer; 2009 Mar; 52(3):364-8. PubMed ID: 18989887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylenetetrahydrofolate reductase C677T polymorphism: association with risk for childhood acute lymphoblastic leukemia and response during the initial phase of chemotherapy in greek patients.
    Chatzidakis K; Goulas A; Athanassiadou-Piperopoulou F; Fidani L; Koliouskas D; Mirtsou V
    Pediatr Blood Cancer; 2006 Aug; 47(2):147-51. PubMed ID: 16123993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.